Clinical significance of plasma Antithrombin III in various liver diseases.
Lists
Only you see this
Abstract
Background : Antithrombin III (AT-III) produced from hepatocytes and endothelial cells is a coagulation inhibitor. The authors investigated the activity levels of AT-III in patients with liver disease and attempt to elucidate the clinical significance of activity levels of AT-III in relation to various liver disease. Methods : This study includes 158 patients with liver disease, who visited the National Police Hospital between October 1997 and March 2002. We performed laboratory tests such as LFT, AFP and either abdominal sonography or abdominal CT. At the same time, AT-III activity levels was measured by chromogenic method using ACL 3000 (IL, Lexington, USA). AT-III activity level of 70-120% was regarded as normal. Results : AT-III activity level of liver cirrhosis patients was decreased along with severity of the disease evaluated by Child-Pugh Classification. AT-III activity level of liver cirrhosis patients and hepatocellular carcinoma patients with liver cirrhosis, whose serum AFP were within normal limits, were 50.112.86% and 75.586.61%, respectively. The difference between the two groups was statistically significant (p
BibTeX
@article{shin2002clinical,
author = {Yo-Sig Shin and Won-Hee Baek and Su-Jin Im and Gyu-Rak Chon and Young-Wook Kim and Jun-Hyoung Kim and Sang‐Joon Park and Yun-Kwon Kim and So-Yon Kim and Young‐Jung Kim and Min-Koo Cho and Gwon-Jun Lee},
title = {{Clinical significance of plasma Antithrombin III in various liver diseases.}},
journal = {The Korean Journal of Internal Medicine},
year = {2002},
}Loading related content...